Bazedoxifene/conjugated estrogens in combination with leuprolide for the treatment of endometriosis
article
OA: gold
CC0
⤵ 4 in-corpus citations
Abstract
Bazedoxifene/conjugated estrogens can be used with leuprolide as effective add-back therapy in premenopausal women with endometriosis without unwanted stimulation of the breasts, CNS (Central Nervous System), or endometrium. Bazedoxifene/conjugated estrogens may be an effective progestin-free alternative to traditional add-back therapies.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (36)
- Bazedoxifene/conjugated estrogens in combination with leuprolide for the treatment of endometriosis via openalex
- Endometriosis via openalex
- Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show? via openalex
- Hormone therapy for endometriosis and surgical menopause via openalex
- Leuprolide Acetate Depot and Hormonal Add-Back in Endometriosis: A 12-Month Study via openalex
- Modern combined oral contraceptives for pain associated with endometriosis via openalex
- Modern combined oral contraceptives for pain associated with endometriosis. via openalex
- Non-steroidal anti-inflammatory drugs for pain in women with endometriosis via openalex
- Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis via openalex
- Oral contraceptives for pain associated with endometriosis via openalex
- Return of Chronic Pelvic Pain From Endometriosis After Raloxifene Treatment via openalex
- Systematic review of the effects of aromatase inhibitors on pain associated with endometriosis via openalex
- Treatment strategies for endometriosis via openalex
- Treatment with Bazedoxifene and Conjugated Estrogens Results in Regression of Endometriosis in a Murine Model1 via openalex
- Treatment with Bazedoxifene, a Selective Estrogen Receptor Modulator, Causes Regression of Endometriosis in a Mouse Model via openalex
- W2049340857 via openalex
- W2051318944 via openalex
- W2056529697 via openalex
- W2066591855 via openalex
- W2073817578 via openalex
- W2091647434 via openalex
- W2105351124 via openalex
- W2149736552 via openalex
- W2325870731 via openalex
- W1985785776 via openalex
- W4211081176 via openalex
- W1976389084 via openalex
- W4236705518 via openalex
- W1973332276 via openalex
- W4255996882 via openalex
- W2007872498 via openalex
- W1964254460 via openalex
- W2015857600 via openalex
- W2017526124 via openalex
- W2025647698 via openalex
- W2037965527 via openalex
Cited by (5)
- The use of conjugated estrogens and bazedoxifene for the management of vasomotor symptoms in premenopausal and menopausal patients with endometriosis: a systematic review 2026
- A review of phase II and III drugs for the treatment and management of endometriosis 2023
- Efficacy of Laparoscopic Surgery Combined With Leuprorelin in the Treatment of Endometriosis Associated With Infertility and Analysis of Influencing Factors for Recurrence 2022
- A comprehensive review of hormonal and biological therapies for endometriosis: latest developments 2019
- Bazedoxifene/conjugated estrogens in combination with leuprolide for the treatment of endometriosis 2018
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:19:43.094626+00:00
License: CC0
· commercial use OK